collecting real world data from novel treatments
Published 7 years ago • 73 plays • Length 2:43Download video MP4
Download video MP3
Similar videos
-
0:32
the importance of obtaining real-world data
-
1:50
the value of moving novel agents into the frontline setting in all
-
2:21
the current state of the art in all and how novel agents are impacting the field
-
1:31
novel treatment agents and how they're changing the mpn field
-
1:09
cll treatment: discussing new data from the last 3 years
-
1:44
real-world outcomes of brexu-cel for r/r b-all: evidence from the cibmtr registry
-
1:03
late effect surveillance following allosct: the publication of new guidelines
-
2:43
gemtuzumab ozogamicin in frontline aml therapy
-
2:02
rwd from insight-mm: duration of therapy and treatment sequencing
-
2:53
real-world data on upfront subcutaneous bortezomib-containing regimens for newly diagnosed myeloma
-
1:27
incorporating new technologies into the real-life classification of aml to guide treatment decisions
-
2:06
how the mpn field has evolved over the years: novel agents, trials, and more
-
1:02
the use of car-t cell products in a real-world setting
-
1:45
how should we utilizing molecular data to improve all treatment?
-
1:53
how novel agents may eliminate the need for transplant in all
-
1:42
applying next-generation sequencing in the diagnosis of rare inherited anemias
-
3:52
car-t for nhl: a first real-world study
-
2:48
the novel icaht grading system to predict toxicity following car t-cell therapy